Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP309117.RAK5ZBNG7dKtM3q91Z0n9de9-wnkz4TPwtp7nZSLNURQg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP309117.RAK5ZBNG7dKtM3q91Z0n9de9-wnkz4TPwtp7nZSLNURQg130_assertion type Assertion NP309117.RAK5ZBNG7dKtM3q91Z0n9de9-wnkz4TPwtp7nZSLNURQg130_head.
- NP309117.RAK5ZBNG7dKtM3q91Z0n9de9-wnkz4TPwtp7nZSLNURQg130_assertion description "[The vaccines used were recombinant vaccinia virus containing the transgenes for CEA and three T-cell costimulatory molecules [B7-1, ICAM-1, and LFA-3, designated recombinant vaccinia (rV)-CEA/TRICOM], with each transgene under the control of individual poxvirus promoters, and a replication-defective avipox virus (fowlpox; rF) containing the same four transgenes (designated rF-CEA/TRICOM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309117.RAK5ZBNG7dKtM3q91Z0n9de9-wnkz4TPwtp7nZSLNURQg130_provenance.
- NP309117.RAK5ZBNG7dKtM3q91Z0n9de9-wnkz4TPwtp7nZSLNURQg130_assertion evidence source_evidence_literature NP309117.RAK5ZBNG7dKtM3q91Z0n9de9-wnkz4TPwtp7nZSLNURQg130_provenance.
- NP309117.RAK5ZBNG7dKtM3q91Z0n9de9-wnkz4TPwtp7nZSLNURQg130_assertion SIO_000772 12384537 NP309117.RAK5ZBNG7dKtM3q91Z0n9de9-wnkz4TPwtp7nZSLNURQg130_provenance.
- NP309117.RAK5ZBNG7dKtM3q91Z0n9de9-wnkz4TPwtp7nZSLNURQg130_assertion wasDerivedFrom befree-20150227 NP309117.RAK5ZBNG7dKtM3q91Z0n9de9-wnkz4TPwtp7nZSLNURQg130_provenance.
- NP309117.RAK5ZBNG7dKtM3q91Z0n9de9-wnkz4TPwtp7nZSLNURQg130_assertion wasGeneratedBy ECO_0000203 NP309117.RAK5ZBNG7dKtM3q91Z0n9de9-wnkz4TPwtp7nZSLNURQg130_provenance.